Alzheimers therapeutics (Scios/Lilly)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAlzheimers therapeutics (Scios/Lilly)
Drug Alias NameAlzheimers therapy (Scios/HMR)beta-amyloid inhibitor (Scios)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScios Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScios IncEli Lilly And CompanyHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A